| Q88811602 | A RandomizEd trial of ENtERal Glutamine to minimIZE thermal injury (The RE-ENERGIZE Trial): a clinical trial protocol |
| Q35355769 | A double blind, randomised, controlled trial of glutamine supplementation in parenteral nutrition |
| Q44552471 | A prospective randomized trial of enteral glutamine in critical illness |
| Q87333802 | A randomized trial of intravenous glutamine supplementation in trauma ICU patients |
| Q41895482 | Alanyl-glutamine dipeptide inhibits hepatic ischemia-reperfusion injury in rats |
| Q36923707 | Alterations in glutamine metabolism and its conversion to citrulline in sepsis |
| Q37667906 | Amino acids - Guidelines on Parenteral Nutrition, Chapter 4 |
| Q42652139 | Artificial nutrition: principles and practice of enteral feeding |
| Q38095905 | Branched-chain amino acid supplementation: impact on signaling and relevance to critical illness |
| Q24797006 | Clinical review: Intensive care follow-up--what has it told us? |
| Q61757070 | Diagnose und Therapie der Sepsis |
| Q44754456 | Diagnosis and therapy of sepsis |
| Q77125580 | Does loss of body protein determine outcome in patients who are critically ill? |
| Q39272777 | Effect of intravenous GLutamine supplementation IN Trauma patients receiving enteral nutrition study protocol (GLINT Study): a prospective, blinded, randomised, placebo-controlled clinical trial |
| Q46467529 | Effects of combined pulse electromagnetic field stimulation plus glutamine on the healing of colonic anastomosis in rats |
| Q44727493 | Effects on skeletal muscle of intravenous glutamine supplementation to ICU patients |
| Q36927395 | Efficacy and Safety of Glutamine-supplemented Parenteral Nutrition in Surgical ICU Patients: An American Multicenter Randomized Controlled Trial. |
| Q34708081 | Efficacy of parenteral nutrition supplemented with glutamine dipeptide to decrease hospital infections in critically ill surgical patients |
| Q33750288 | Endogenous glutamine production in critically ill patients: the effect of exogenous glutamine supplementation |
| Q26797452 | Enteral glutamine supplementation in critically ill patients: a systematic review and meta-analysis |
| Q77362586 | Enteral nutrition in intensive care patients: a practical approach. Working Group on Nutrition and Metabolism, ESICM. European Society of Intensive Care Medicine |
| Q35107676 | Glutamine Supplementation In Vitro and In Vivo, in Exercise and in Immunodepression |
| Q38562404 | Glutamine Supplementation in Intensive Care Patients: A Meta-Analysis of Randomized Clinical Trials |
| Q35804639 | Glutamine and glutathione at ICU admission in relation to outcome |
| Q46060697 | Glutamine attenuates nitric oxide synthase expression and mitochondria membrane potential decrease in interleukin-1beta-activated rat hepatocytes |
| Q46406443 | Glutamine decreases the duration of postoperative ileus after abdominal surgery: an experimental study of conscious dogs |
| Q34591145 | Glutamine depletion induces murine neonatal melena with increased apoptosis of the intestinal epithelium |
| Q41821248 | Glutamine in critically ill patients: is it a fundamental nutritional supplement? |
| Q39386551 | Glutamine supplementation |
| Q24193714 | Glutamine supplementation for critically ill adults |
| Q33752877 | Glutamine supplementation in the critically ill: friend or foe? |
| Q95795661 | Glutamine supplementation to critically ill patients? |
| Q80512725 | Glutamine supplements in the critically ill |
| Q41683026 | Glutamine up-regulates MAPK phosphatase-1 induction via activation of Ca2+→ ERK cascade pathway |
| Q24792606 | Glutamine-enriched enteral nutrition in very low birth weight infants. Design of a double-blind randomised controlled trial [ISRCTN73254583] |
| Q43560999 | Glutamine: a life-threatening deficiency in the critically ill? |
| Q26780124 | Glutamine: an obligatory parenteral nutrition substrate in critical care therapy |
| Q24791658 | Gut mucosal and plasma concentrations of glutamine: a comparison between two enriched enteral feeding solutions in critically ill patients |
| Q37107283 | Immunomodulation in surgical practice |
| Q34682217 | Immunonutrition |
| Q36955260 | Influence of early antioxidant supplements on clinical evolution and organ function in critically ill cardiac surgery, major trauma, and subarachnoid hemorrhage patients |
| Q37667914 | Intensive medicine - Guidelines on Parenteral Nutrition, Chapter 14 |
| Q48412967 | Intravenous glutamine supplementation to head trauma patients leaves cerebral glutamate concentration unaffected |
| Q41563526 | Mechanism of glutamine inhibition of cytosolic phospholipase a2 (cPLA2 ): Evidence of physical interaction between glutamine-Induced mitogen-activated protein kinase phosphatase-1 and cPLA2. |
| Q80155310 | Missing effect of glutamine supplementation on the surgical outcome after pancreaticoduodenectomy for periampullary tumors: a prospective, randomized, double-blind, controlled clinical trial |
| Q35543961 | NICHD neonatal research network: contributions and future challenges |
| Q46991192 | Nutrition and immunonutrition in septic patients |
| Q44698937 | Nutrition and renal insufficiency |
| Q36279517 | Nutrition support for patients in the intensive care unit |
| Q35069116 | Nutritional papers in ICU patients: what lies between the lines? |
| Q36414289 | Nutritional support in the premature newborn |
| Q28367437 | Oral feeding with glutamine prevents lymphocyte and glutathione depletion of Peyer's patches in endotoxemic mice |
| Q44628133 | Oral glutamine attenuates surgical manipulation-induced alterations in the intestinal brush border membrane |
| Q46562465 | Parenteral glutamine increases serum heat shock protein 70 in critically ill patients |
| Q38205494 | Parenteral glutamine supplementation in critical illness: a systematic review |
| Q37481645 | Parenteral nutrition in patients with renal failure - Guidelines on Parenteral Nutrition, Chapter 17. |
| Q34486267 | Prolonged continuous intravenous infusion of the dipeptide L-alanine- L-glutamine significantly increases plasma glutamine and alanine without elevating brain glutamate in patients with severe traumatic brain injury |
| Q36151254 | Randomised trial of glutamine and selenium supplemented parenteral nutrition for critically ill patients. Protocol Version 9, 19 February 2007 known as SIGNET (Scottish Intensive care Glutamine or seleNium Evaluative Trial) |
| Q33816654 | Recent advances: recent advances in intensive care |
| Q33858707 | The Effect of Nutritional Status in the Pathogenesis of Critical Illness Myopathy (CIM) |
| Q39302506 | The Roles of Glutamine in the Intestine and Its Implication in Intestinal Diseases |
| Q37206693 | The effect of glutamine infusion on the inflammatory response and HSP70 during human experimental endotoxaemia |
| Q33754020 | The effect of glutamine therapy on outcomes in critically ill patients: a meta-analysis of randomized controlled trials |
| Q83879396 | The effect of glutamine-supplemented total parenteral nutrition on nutrition and intestinal absorptive function in a rat model |
| Q35543987 | The multiple negative randomized controlled trials in perinatology—why? |
| Q37445001 | Treatment of acute pancreatitis: focus on medical care. |
| Q82237707 | [Immunonutrition after trauma] |
| Q85963998 | [Immunonutrition in intensive care medicine] |
| Q84280892 | [Nutrition in intensive care medicine] |
| Q80305414 | [Prevention and therapy of acute renal failure: the importance of metabolic intervention] |